TLR-4 blockade also significantly reduced LPS-dependent tumour cell vitronectin adhesion (Figure 5D) and in vitro tumour cell invasion for SW480 and SW620 cell lines (Figure 5E). The gene discussed is TLR4; the disease is neoplasm.